Multi-institutional phase 2 study of TLK286 (TELCYTA™, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer

✍ Scribed by J.J. KAVANAGH; D.M. GERSHENSON; H. CHOI; L. LEWIS; K. PATEL; G.L. BROWN; A. GARCIA; D.R. SPRIGGS

• Book ID: 109085292
• Publisher: John Wiley and Sons
• Year: 2005
• Tongue: English
• Weight: 90 KB
• Volume: 15
• Category: Article
• ISSN: 1048-891X
• DOI: 10.1111/j.1525-1438.2005.00114.x